Papp Z, Tóth-Pál E, Papp C, Tóth Z, Szabó M, Veress L, Török O
I Department of Obstetrics and Gynecology, Semmelweis University Medical School of Budapest, Hungary.
Ultrasound Obstet Gynecol. 1995 Nov;6(5):320-6. doi: 10.1046/j.1469-0705.1995.06050320.x.
The objective of this study was to evaluate the effectiveness of the measurement of maternal serum alpha-fetoprotein (MSAFP) at 16 weeks and a subsequent routine ultrasound screening at 18-20 weeks' gestation and the impact on the birth prevalence of congenital structural anomalies in an unselected pregnant population of Hungary in a prospective epidemiological study. A total of 63,794 pregnant women (representing one-sixth of the population of Hungary) were offered this screening program over 3 years (1988-90). Of the pregnant population, 75.7% (48,312) received MSAFP screening and in 81.0% (51,675), at least one ultrasound scan was performed. In the screened pregnancies, 496 craniospinal, thoraco-abdominal, urogenital and other severe major anomalies occurred; 317 were detected at 18-20 weeks (sensitivity 63.1%; specificity 100.0%; positive predictive value 100.0%). The sensitivity of ultrasound scanning was significantly higher (p < 0.05) than that of the MSAFP screening. (At the time of ultrasound scanning the MSAFP value was known.) In this study, the less serious anomalies such as hydrocele, hypospadias and undescended testicle were not systematically searched for, but the birth prevalences were calculated. The overall mid-trimester prevalence of severe plus less severe major anomalies was 2.26%. The birth prevalences of severe major anomalies were 0.57 (craniospinal), 4.36 (thoracoabdominal and urogenital) and 1.21 (other severe) per 1000. These values were lower than the mid-trimester prevalences which were 2.94, 5.20 and 2.06 per 1000, respectively. The prevalence values at the age of 1 year were also calculated (0.36, 2.21, 0.54 per 1000, respectively). We conclude that our screening program with availability of termination of pregnancy could significantly (p < 0.05) reduce the prevalence of severe major abnormalities at birth. Training programs in cardiac scanning are required.
本研究的目的是在一项前瞻性流行病学研究中,评估匈牙利未经过筛选的孕妇群体在孕16周时测量母血清甲胎蛋白(MSAFP)以及随后在孕18 - 20周进行常规超声筛查的有效性,以及对先天性结构异常出生患病率的影响。在3年(1988 - 1990年)期间,共有63794名孕妇(占匈牙利人口的六分之一)接受了该筛查项目。在孕妇群体中,75.7%(48312名)接受了MSAFP筛查,81.0%(51675名)至少进行了一次超声扫描。在接受筛查的妊娠中,发生了496例颅脊柱、胸腹、泌尿生殖系统及其他严重的主要异常;其中317例在孕18 - 20周时被检测出(敏感性63.1%;特异性100.0%;阳性预测值100.0%)。超声扫描的敏感性显著高于(p < 0.05)MSAFP筛查。(在进行超声扫描时,MSAFP值已可知。)在本研究中,未系统地查找诸如鞘膜积液、尿道下裂和隐睾等不太严重的异常情况,但计算了其出生患病率。孕中期严重及不太严重的主要异常的总体患病率为2.26%。严重主要异常的出生患病率分别为每1000例中有0.57例(颅脊柱)、4.36例(胸腹和泌尿生殖系统)和1.21例(其他严重情况)。这些数值低于孕中期的患病率,孕中期患病率分别为每1000例中有2.94例、5.20例和2.06例。还计算了1岁时的患病率(分别为每1000例中有0.36例、2.21例、0.54例)。我们得出结论,我们的可进行终止妊娠的筛查项目可显著(p < 0.05)降低严重主要异常的出生患病率。需要开展心脏扫描培训项目。